altretamine has been researched along with Carcinoma, Colloid in 8 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-seven evaluable patients with advanced ovarian carcinoma were randomized to receive either a combination of hexamethylmelamine, cyclophosphamide, methotrexate and 5-fluorouracil (Hexa-CAF) or high-dose cyclophosphamide alone given intravenously intermittently." | 5.05 | Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF). ( Carmo-Pereira, J; Costa, FO; Henriques, E; Ricardo, JA, 1981) |
| "Thirty-eight women with advanced ovarian cancer resistant to alkylating-agent chemotherapy were treated with a combination of hexamethylmelamine and cisplatin." | 1.26 | Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy. ( Arseneau, JC; Davis, TE; Einhorn, N; Kaplan, BH; Pagano, M; Tunca, JC; Vogl, SE, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmo-Pereira, J | 1 |
| Costa, FO | 1 |
| Henriques, E | 1 |
| Ricardo, JA | 1 |
| Vogl, SE | 1 |
| Pagano, M | 1 |
| Davis, TE | 1 |
| Einhorn, N | 1 |
| Tunca, JC | 1 |
| Kaplan, BH | 1 |
| Arseneau, JC | 1 |
| Honetz, N | 1 |
| Pino y Torres, JL | 1 |
| Bross, DS | 1 |
| Hernandez, E | 2 |
| Rosenshein, N | 1 |
| Klein, JL | 1 |
| Ettinger, DS | 2 |
| Leichner, PK | 1 |
| Order, SE | 2 |
| Rosenshein, NB | 1 |
| Villar, J | 1 |
| Dillon, MB | 1 |
| Brower, MS | 1 |
| Coleman, M | 1 |
| Pasmantier, MW | 1 |
| Silver, RT | 1 |
| Mamaril, AP | 1 |
| Quiguyan, CC | 1 |
| Ang, PT | 1 |
| Kavanagh, J | 1 |
| Rizel, S | 1 |
| Biran, S | 1 |
| Anteby, SO | 1 |
| Brufman, G | 1 |
| Sulkes, A | 1 |
| Milwidsky, A | 1 |
| Weshler, Z | 1 |
| Fuks, Z | 1 |
1 review available for altretamine and Carcinoma, Colloid
| Article | Year |
|---|---|
[Progress in the chemotherapy of ovarian cancer].
Topics: Adenocarcinoma, Mucinous; Altretamine; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; C | 1982 |
2 trials available for altretamine and Carcinoma, Colloid
| Article | Year |
|---|---|
Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Antineoplastic Agents; Carcinoma; Clinical Trial | 1981 |
Multimodality treatment of patients with advanced ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Altretamine; Antibodies, Neoplasm; Carcinoma; Cisplatin; Clinical Trials a | 1982 |
5 other studies available for altretamine and Carcinoma, Colloid
| Article | Year |
|---|---|
Hexamethylmelamine and cisplatin in advanced ovarian cancer after failure of alkylating-agent therapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Cisplatin; Cystadenocarcinoma; D | 1982 |
Alternating multiagent chemotherapy for advanced ovarian cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Altretamine; Antineoplastic Agents; Cisplatin; Cyclophosph | 1983 |
Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Altretamine; Antineoplastic Combined Chemotherapy Protocol | 1984 |
Management of recurrent ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 1989 |
Combined modality treatment for stage III ovarian carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Altretamine; Antineoplastic Combined Chemothe | 1985 |